hypoglycemic agents in glutathione agent 1 | Hypoglycemic Agent Xia & He Publishing

Repositioning FDA-approved drugs in combination with epigenetic drugs to reprogram colon cancer epigenome

Patients with a known hypersensitivity to iron dextran should not use this product

This case illustrates a variant anaphylactoid reaction to intravenously administered acetylcysteine and emphasizes the need for practitioners to consider the potential for these reactions prior to initiation of therapy and indicates appropriate treatment of these reactions

Benzothiadiazole and L-2-oxothiazolidine-4-carboxylic acid reduced the severity of Sharka symptoms in pea leaves: effect on the antioxidative metabolism at subcellular level